Owens & Minor sells P&HS segment to Platinum Equity, holds minority stake
Owens & Minor, Inc. announced that it has entered into a definitive agreement for the sale of the Company’s Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive home-based care space. This transaction will allow the company to focus on a simpler business model and allow for a more appropriate valuation as a leader in this segment, according to a release.
“Today’s announcement represents another critical step forward in the strategic transformation of Owens & Minor into a leading, pure play home based care platform,” said Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor. “With the definitive agreement in place for Products & Healthcare Services, we will remain laser-focused on transforming the Company into a pure-play home-based care business that will drive even more value for our Patient Direct stakeholders. Going forward, we will be positioned among the leaders in a dynamic market where we will be able to capitalize on our leading brands and long-standing record of putting the patient first while delivering consistent revenue and profit growth. The ability to dedicate our resources to the more profitable part of the legacy business will be value-enhancing for many years to come.”
Henry Schein’s 2025 Practice Pink® Program brings health care communities together worldwide for cancer awareness
Henry Schein, Inc. kicked off its 2025 Practice Pink® program, an annual global initiative aimed at raising awareness and supporting efforts to prevent, detect, and treat cancer. Over the past 19 years, the program has contributed more than US $2.1 million to cancer-related causes, helping to advance vital research, expand access to care, and promote health care worldwide.
Through the program, Henry Schein assists dental and medical health care professionals in raising awareness and providing support to help find a cure for cancer. By offering its customers a variety of pink products, including health care consumables, practice supplies, and apparel, the Practice Pink program advances important cancer research and prevention efforts.
The Practice Pink program supports the American Cancer Society and the Joe Andruzzi Foundation in the U.S., as well as various organizations in Europe, including ALADINA (Spain), KiKa (The Netherlands), LILT (Italy), Odyssea (France), and others.
BD celebrates 55 years of manufacturing excellence and impact in Sumter, S.C.
BD commemorated 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout its history has been a core site within the Company’s extensive U.S. manufacturing footprint.
Since opening its doors and producing its first glass syringe barrel in 1970 with 25 employees, the Sumter facility has grown into one of BD’s largest and most strategically important manufacturing sites, supporting health care providers and patients around the world. Today, the facility spans more than 600,000 square feet and employs approximately 900 associates, producing billions of products each year, including the BD Vacutainer® blood collection products, that are critical to the backbone of health care in areas including diagnostics, treatment and medical research.